Speaker illustration

Doctor Katrin Kemp Gudmundsdottir

Karolinska Institutet, Stockholm (Sweden)

Using NT-proBNP to screen patients with Afib: results from the STROKESTOP II trial.

Event: ESC Congress 2021 - The Digital Experience

Topic: Biomarkers

Session: Cardiac biomarkers are here to stay

Thumbnail

NT-proBNP: a valuable marker to screen for Atrial Fibrillation.

Event: ESC Congress 2021 - The Digital Experience

Topic: Arrhythmias, General

Session: Atrial fibrillation screening and biomarkers to assess stroke and bleeding risks in atrial fibrillation patients

Thumbnail

NT-proBNP: a valuable marker to screen for Atrial Fibrillation.

Event: ESC Congress 2021 - The Digital Experience

Topic: Arrhythmias, General

Session: Atrial fibrillation screening and biomarkers to assess stroke and bleeding risks in atrial fibrillation patients

Thumbnail

Pulse palpation and history of palpitations in atrial fibrillation screening - preliminary results from the strokestop 2 study

Event: ESC Congress 2018

Topic: Diagnostic Methods

Session: Atrial fibrillation - Stroke prevention

Thumbnail

Mass screening for atrial fibrillation using n-terminal pro b-type natriuretic peptide - preliminary results from the strokestop 2 study

Event: ESC Congress 2018

Topic: Epidemiology, Prognosis, Outcome

Session: Atrial fibrillation - Detection, treatment, outcomes

Thumbnail

This platform is supported by

logo Novo Nordisk